Lifeward Ltd. CEO Departs; Appoints Interim CEO and New CFO

What Happened
Lifeward Ltd. announced that President and CEO Mark Grant resigned and left his Board seat effective August 31, 2026, under a separation agreement. Mr. Grant will provide transition support as a Senior Advisor through September 30, 2026 under a consulting agreement for $40,000; his unvested equity awards ceased vesting and are forfeited as of August 31, 2026. The Board appointed Josh Hexter as Interim Chief Executive Officer effective September 1, 2026, and named Rami Aviram as Chief Financial Officer effective November 1, 2026.

Key Details

• CEO departure effective August 31, 2026; no cash severance paid; consulting fee of $40,000 for support through September 30, 2026.
• Unvested equity awards held by Mr. Grant ceased vesting and were forfeited as of August 31, 2026.
• Josh Hexter (age 56), currently Chief Operating & Business Officer of controlling shareholder Oramed, appointed Interim CEO effective September 1, 2026; employment pay: NIS 100,000/month + NIS 5,000 commuting allowance (or company car); agreement approved by the Compensation Committee and Board and will be submitted for shareholder approval.
• Rami Aviram (age 47) appointed CFO effective November 1, 2026; pay: NIS 70,000/month + NIS 5,000 commuting allowance; Mr. Aviram succeeds Almog Adar (departure effective September 30, 2026).
• Employment agreements and the separation/consulting agreements will be filed as exhibits to the Company’s Form 10-Q for the quarter ending September 30, 2026.

Why It Matters
These filings document a top-level management change and a planned leadership transition. Investors should note the immediate operational facts: the CEO left with no cash severance, received short-term consulting support for $40,000, and forfeited unvested equity awards. The interim CEO is affiliated with the company’s controlling shareholder (Oramed) and his appointment and compensation will be subject to shareholder approval, as disclosed. The new CFO will begin November 1, 2026, with an interim financial officer serving in the interim—items that may affect continuity in financial reporting and executive decision-making in the near term.